Natash Leighl
Oncologist specializing in lung cancer treatments and co-chair of the ASCO Living Guideline on stage IV NSCLC with driver alterations.
Best podcasts with Natash Leighl
Ranked by the Snipd community
Feb 28, 2024 • 14min
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.3 Part 2
Dr. Natash Leighl and Dr. Jyoti Patel discuss the updated living guideline for stage IV NSCLC with driver alterations, covering therapies for EGFR, ALK, ROS1, BRAFV600E, MET exon skipping mutation, RET rearrangement, NTRK rearrangement, HER2, and KRAS G12C. They emphasize key changes, recent trials, importance of biomarker testing, and impact on clinicians and patients. Stay tuned for future updates.
